This Fund Just Viridian: Key Takeaways for Investors
A major fund recently trimmed its stake in Viridian Therapeutics, signaling potential rotation rather than a verdict ...
This page covers the main factors that move indices, including earnings, policy, and macro conditions, with tips for interpreting changes.
28,658 articlesA major fund recently trimmed its stake in Viridian Therapeutics, signaling potential rotation rather than a verdict ...
KB Home's Q1 2026 results shed light on the company’s earnings trajectory and the housing market dynamics. This guide...
Investing hinges on leadership as much as numbers. This guide dives into how Josh D'Amaro's new approach could influe...
One year into Lip-Bu Tan’s tenure, Intel trimmed costs, pushed 18A production forward, and rebuilt the balance sheet—...
Inflation quietly squeezes every dollar. This guide lays out clear, practical steps to protect your family's budget—f...
P3 Health's Q1 2026 results set the stage for an important year in health services. This analysis breaks down the ear...
A single company’s three engines—cloud, ads, and chips—are powering a persistent multi‑billion revenue trajectory, ev...
Ford stock has surged over the past month as investors shift focus from traditional auto earnings to Ford Energy and ...
Tesla's Q2 delivery figures offer a clear window into demand trends and pricing power. This guide breaks down what to...
A bankruptcy filing forced Spirit Airlines to suspend operations, triggering a scramble for affordable summer travel ...
When Warren Buffett stepped aside, Greg Abel took the wheel at Berkshire Hathaway. This article breaks down his first...
Two seniors were manipulated into mailing cash after alarming scam calls, triggering a statewide investigation and a ...